Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor

Journal of Pediatric Surgery

Volumn 35, Issue 1, 2000, Pages 30-33

  Rowe, Dorothy H ^a   Huang, Jianzhong ^a   Kayton, Mark L ^a   Thompson, Richard ^a   Troxel, Andrea ^a   O'Toole, Kathleen M ^a   Yamashiro, Darrell ^a   Stolar, Charles J H ^a   Kandel, Jessica J ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Metastasis; Vascular endothelial growth factor; Wilms' tumor

Indexed keywords

ANGIOGENIC FACTOR; VASCULOTROPIN RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; CANCER TRANSPLANTATION; CONFERENCE PAPER; FEMALE; LUNG METASTASIS; MOUSE; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STATISTICAL ANALYSIS; TUMOR CELL CULTURE; TUMOR GROWTH; TUMOR VOLUME;

EID: 0033979730     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(00)80008-1     Document Type: Conference Paper

References (7)

1. M Kayton D Rowe K O'Toole Metastasis correlates with production of Vascular Endothelial Growth Factor in a murine model of human Wilms tumor J Pediatr Surg 34 1999 743 748
2. D Leung G Cachianes W Kuang Vascular endothelial growth factor is a secreted endothelial cell mitogen Science 246 1989 1306
3. D Senger L Van De Water L Brown Vascular permeability factor (VPF, VEGF) in tumor biology Cancer Metastasis Rev 12 1993 303 324
4. W Roberts G Palade Neovasculature induced by vascular endothelial growth factor is fenestrated Cancer Res 57 1997 765 772
5. M Gordon M Talpaz M Margolin Trial of recombinant humanized monoclonal anti-vascular endothelial growth factor (anti-VEGF mab) in patients with metastatic cancer Proc ASCO 17 1998 210a
6. T Boehm J Folkman T Browder Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature 390 1997 404 407
7. H Mauceri N Hanna M Beckett Combined effects of angiostatin and ionizing radiation in antitumor therapy Nature 394 1998 287 291